NCT06835907View on ClinicalTrials.gov

Baclofen for Anxiety and Alcohol Use Disorder (AUD): an Open Label Study

NARecruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 28, 2024

Primary Completion Date

December 30, 2029

Study Completion Date

December 30, 2029

Conditions
Alcohol Use Disorder (AUD)
Interventions
OTHER

Questionnaires

Questionnaires include: the Alcohol Use Disorder Identification Test (AUDIT), Composite Autonomic Symptom Score (COMPASS-31), Depression Anxiety Stress Scale (DASS-21), Drug Desire Questionnaire (DDQ), Drinking Motives Questionnaire short form (DMQ-SF), Mini International Neuropsychiatric Interview (MINI), PROMIS-alcohol, Timeline Follow Back (TLFB) and Visual Analog Scale for craving (VAS).

Trial Locations (1)

1090

RECRUITING

Universitair Ziekenhuis Brussel, Jette

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER